The challenge of applying electrodes to a 3D geometry used in aseptic production | Novo Nordisk

Novo Nordisk A/S supplies nearly 50% of the world’s insulin for treatment of diabetes, and 34 million people are using our diabetes care products. We are also develop and supplying medicine for growth disorder, hemophilia, and obesity.

In Manufacturing Development - AP Innovation & Development, we are working on concepts for future aseptic production. As part of this we are developing a new concept, where we need to place a conductive pattern on the outside of the 3D surface of a plastic part. On top of being in a aseptic environment the conductive pattern and the plastic part will also have drug contact, so the materials have to be compatible with our drug products. This gives a very limited solution space and I would love to get suggestions on how to do it.

SAVE THE DATE